Edwards Lifesciences Corporation APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Edwards Lifesciences Corporation (EW) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $42.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $42.20M, a 12.53% increase year-over-year.
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $45.40M, a 12.94% increase year-over-year.
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $41.20M, a 2.14% decline year-over-year.
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $37.50M, a 14.58% decline year-over-year.
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $158.10M, a 3.48% decline from fiscal 2024.
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $163.80M, a 17.50% increase from fiscal 2023.
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $139.40M, a 9.94% increase from fiscal 2022.
- Edwards Lifesciences Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $126.80M, a 16.01% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $42.20M 10-Q · filed 2026-08-04 | $87.60M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $45.40M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $158.10M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $41.20M 10-Q · filed 2025-11-05 | $78.70M derived: sum of 2 quarters · filed 2026-08-04 | $118.90M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $37.50M 10-Q · filed 2026-08-04 | $77.70M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $40.20M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $163.80M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $42.10M 10-Q · filed 2025-11-05 | $86.00M derived: sum of 2 quarters · filed 2025-11-05 | $130.60M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $43.90M 10-Q · filed 2025-11-05 | $88.50M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $44.60M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $139.40M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $32.60M 10-Q · filed 2024-11-06 | $70.00M derived: sum of 2 quarters · filed 2024-11-06 | $108.90M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $37.40M 10-Q · filed 2024-11-06 | $76.30M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $38.90M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $126.80M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $30.30M 10-Q · filed 2023-10-27 | $66.50M derived: sum of 2 quarters · filed 2023-10-27 | $98.90M derived: sum of 3 quarters · filed 2023-10-27 | |
| 2022-06-30 | $36.20M 10-Q · filed 2023-10-27 | $68.60M derived: sum of 2 quarters · filed 2023-10-27 | ||
| 2022-03-31 | $32.40M 10-Q · filed 2023-10-27 | |||
| 2021-12-31 | $109.30M 10-K · filed 2024-02-12 | |||
| 2021-09-30 | $26.60M 10-Q · filed 2022-10-28 | $56.90M derived: sum of 2 quarters · filed 2022-10-28 | $85.10M derived: sum of 3 quarters · filed 2022-10-28 | |
| 2021-06-30 | $30.30M 10-Q · filed 2022-10-28 | $58.50M derived: sum of 2 quarters · filed 2022-10-28 | ||
| 2021-03-31 | $28.20M 10-Q · filed 2022-10-28 | |||
| 2020-12-31 | $92.60M 10-K · filed 2023-02-13 | |||
| 2020-09-30 | $23.00M 10-Q · filed 2021-10-29 | $47.80M derived: sum of 2 quarters · filed 2021-10-29 | $71.70M derived: sum of 3 quarters · filed 2021-10-29 | |
| 2020-06-30 | $24.80M 10-Q · filed 2021-10-29 | $48.70M derived: sum of 2 quarters · filed 2021-10-29 | ||
| 2020-03-31 | $23.90M 10-Q · filed 2021-10-29 | |||
| 2019-12-31 | $81.30M 10-K · filed 2022-02-14 | |||
| 2019-09-30 | $19.80M 10-Q · filed 2020-10-26 | $42.10M derived: sum of 2 quarters · filed 2020-10-26 | $62.90M derived: sum of 3 quarters · filed 2020-10-26 | |
| 2019-06-30 | $22.30M 10-Q · filed 2020-10-26 | $43.10M derived: sum of 2 quarters · filed 2020-10-26 | ||
| 2019-03-31 | $20.80M 10-Q · filed 2020-10-26 | |||
| 2018-12-31 | $71.00M 10-K · filed 2021-02-12 | |||
| 2018-09-30 | $17.40M 10-Q · filed 2019-10-25 | $36.60M derived: sum of 2 quarters · filed 2019-10-25 | $55.00M derived: sum of 3 quarters · filed 2019-10-25 | |
| 2018-06-30 | $19.20M 10-Q · filed 2019-10-25 | $37.60M derived: sum of 2 quarters · filed 2019-10-25 | ||
| 2018-03-31 | $18.40M 10-Q · filed 2019-10-25 | |||
| 2017-12-31 | $61.60M 10-K · filed 2020-02-14 | |||
| 2016-12-31 | $56.90M 10-K · filed 2019-02-15 | |||
| 2015-12-31 | $49.90M 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $48.30M 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $47.40M 10-K · filed 2016-02-19 | |||
| 2012-12-31 | $42.10M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | $35.00M 10-K · filed 2014-02-28 | |||
| 2010-12-31 | $29.30M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $28.30M 10-K · filed 2012-02-27 | |||
| 2008-12-31 | $28.70M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |